<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33667/2078-5631-2019-4-33(408)-44-47</article-id><article-id custom-type="elpub" pub-id-type="custom">medalphabet-1392</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Генетика и эпигенетика пролапса органов малого таза</article-title><trans-title-group xml:lang="en"><trans-title>Genetics and epigenetics of pelvic organs prolapse</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титов</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Titov</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к. м. н., зав. отделением гинекологии</p><p>г. Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дикке</surname><given-names>Г. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Dikke</surname><given-names>G. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д. м. н., доцент, проф. кафедры акушерства и гинекологии с курсом репродуктивной медицины</p><p>г. Санкт-Петербург </p></bio><bio xml:lang="en"><p>Saint Petersburg</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Объединенная больница с поликлиникой» Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>United Hospital and Polyclinic of the Administrative Department of the President of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ЧОУ ДПО «Академия медицинского образования имени Ф. И. Иноземцева»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academy of Medical Education n. a. F. I. Inozemtsev</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>01</month><year>2020</year></pub-date><volume>4</volume><issue>33</issue><issue-title>Современная гинекология</issue-title><fpage>44</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Титов Д.С., Дикке Г.Б., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Титов Д.С., Дикке Г.Б.</copyright-holder><copyright-holder xml:lang="en">Titov D.S., Dikke G.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/1392">https://www.med-alphabet.com/jour/article/view/1392</self-uri><abstract><p>Идентификация генетических вариантов, лежащих в основе наследственности пролапса тазовых органов (ПТО), помогает выявить полезные маркеры для оценки клинического риска, прогноза и ответа на лечение. Выявлена ассоциация полиморфизмов в гене ADRB 3 с гиперактивным мочевым пузырем и в гене COL1A1 с ПТО. Мутация АА генотипа COL3A1 rs1800255 повышает вероятность ПТО в 4,8 раза. Имеются доказательства вовлеченности в развитие ПТО генов группы деградации экстрацеллюлярного матрикса (ЭЦМ), в которую входят гены, кодирующие матриксные металлопротеиназы. В ходе изучения заболеваний соединительной ткани была выявлена их синтропность, обусловленная генетически в виде общего рискового гаплотипа гена FBLN 5. Значение эпигенетических механизмов для развития ПТО показано в виде супрессии гена лизилоксидазы (ЛО). До настоящего времени не ясна роль факторов, индуцирующих изменение эпигенетической регуляции и приводящих к появлению клинических симптомов пролапса.</p></abstract><trans-abstract xml:lang="en"><p>Identification of the genetic variants underlying the heredity of pelvic organ prolapse helps to identify useful markers for assessing clinical risk, prognosis and response to treatment. An association of polymorphisms in the ADRB 3 gene with an overactive bladder and in the COL1A1 gene with PTO was detected. AA mutation of the COL3A1 rs1800255 genotype increases the probability of VET by 4.8 times. There is evidence of involvement in the development of PTO genes of the extracellular matrix degradation group (ECM), which includes genes encoding matrix metalloproteinases. During the study of diseases of the connective tissue, their syntropy was revealed, which is genetically determined as a common risk haplotype of the FBLN 5 gene. The significance of epigenetic mechanisms for the development of VET is shown in the form of lysyl oxidase (LO) gene suppression. So far, the role of factors that induce changes in epigenetic regulation and lead to the appearance of clinical symptoms of prolapse is not clear.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пролапс тазовых органов</kwd><kwd>недержание мочи</kwd><kwd>патогенез</kwd><kwd>генетические маркеры</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pelvic organ prolapse</kwd><kwd>urinary incontinence</kwd><kwd>pathogenesis</kwd><kwd>genetic markers</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Буянова С. Н., Щукина Н. А., Зубова Е. С., Сибряева В. А., Рижинашвили И. Д. Пролапс гениталий. Российский вестник акушера-гинеколога. 2017; 17 (1): 37–45. DOI: 10.17116/rosakush201717137–45.</mixed-citation><mixed-citation xml:lang="en">Буянова С. Н., Щукина Н. А., Зубова Е. С., Сибряева В. А., Рижинашвили И. Д. Пролапс гениталий. Российский вестник акушера-гинеколога. 2017; 17 (1): 37–45. DOI: 10.17116/rosakush201717137–45.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nygaard I., Barber M. D., Burgio K. L. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300: 1311–16.</mixed-citation><mixed-citation xml:lang="en">Nygaard I., Barber M. D., Burgio K. L. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300: 1311–16.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Сухих Г. Т., Данилов А. Ю., Боташева Д. А. Роль иммуногистохимических и генетических факторов в уточнении этиологии и патогенеза пролапса гениталий у женщин. Российский вестник кушера-гинеколога. 2012; 2: 47–50.</mixed-citation><mixed-citation xml:lang="en">Сухих Г. Т., Данилов А. Ю., Боташева Д. А. Роль иммуногистохимических и генетических факторов в уточнении этиологии и патогенеза пролапса гениталий у женщин. Российский вестник кушера-гинеколога. 2012; 2: 47–50.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Eleje GU, Udegbunam OI, Ofojebe CJ, Adichie CV. Determinants and management outcomes of pelvic organ prolapse in a low resource setting. Ann Med Health Sci Res 2014; 4: 796–801. DOI: 10.4103/2141–9248.141578.</mixed-citation><mixed-citation xml:lang="en">Eleje GU, Udegbunam OI, Ofojebe CJ, Adichie CV. Determinants and management outcomes of pelvic organ prolapse in a low resource setting. Ann Med Health Sci Res 2014; 4: 796–801. DOI: 10.4103/2141–9248.141578.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Walker G. J., Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int. Urogynecol. J. 2011; 22 (2): 127–35. DOI: 10.1007/s00192–010–1215–0.</mixed-citation><mixed-citation xml:lang="en">Walker G. J., Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: review of prevalence and risk factors. Int. Urogynecol. J. 2011; 22 (2): 127–35. DOI: 10.1007/s00192–010–1215–0.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dietz H. P. Genetics of pelvic organ prolapse: comment. Int Urogynecol J. 2012; 23 (4): 509–10. DOI: 10.1007/s00192–011–1638–2.</mixed-citation><mixed-citation xml:lang="en">Dietz H. P. Genetics of pelvic organ prolapse: comment. Int Urogynecol J. 2012; 23 (4): 509–10. DOI: 10.1007/s00192–011–1638–2.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Campeau L, Gorbachinsky I, Badlani GH, Andersson KE. Pelvic floor disorders: linking genetic risk factors to biochemical changes. BJU Int. 2011; 108 (8): 1240–7. DOI: 10.1111/j.1464–410X.2011.10385.x.</mixed-citation><mixed-citation xml:lang="en">Campeau L, Gorbachinsky I, Badlani GH, Andersson KE. Pelvic floor disorders: linking genetic risk factors to biochemical changes. BJU Int. 2011; 108 (8): 1240–7. DOI: 10.1111/j.1464–410X.2011.10385.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Giri A, Wu JM, Ward RM, Hartmann KE, Park AJ, North KE, et al. (2015) Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women’s Health Initiative. PLoS ONE. 2015; 10 (11): e0141647. DOI: 10.1371/journal.pone.0141647.</mixed-citation><mixed-citation xml:lang="en">Giri A, Wu JM, Ward RM, Hartmann KE, Park AJ, North KE, et al. (2015) Genetic Determinants of Pelvic Organ Prolapse among African American and Hispanic Women in the Women’s Health Initiative. PLoS ONE. 2015; 10 (11): e0141647. DOI: 10.1371/journal.pone.0141647.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Buchsbaum G. M., Duecy E. E. Incontinence and pelvic organ prolapse in parous/ nulliparous pairs of identical twins. Neurourol Urodyn. 2008; 27: 496–8.</mixed-citation><mixed-citation xml:lang="en">Buchsbaum G. M., Duecy E. E. Incontinence and pelvic organ prolapse in parous/ nulliparous pairs of identical twins. Neurourol Urodyn. 2008; 27: 496–8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sliekerten Hove M. C.P., Pool-Goudzwaard A.L., Eijkemans M. J.C., Steegers-Theunissen R.P.M., Burger C. W., Vierhout M. E. Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol 2009; 200 (184): e1–7.</mixed-citation><mixed-citation xml:lang="en">Sliekerten Hove M. C.P., Pool-Goudzwaard A.L., Eijkemans M. J.C., Steegers-Theunissen R.P.M., Burger C. W., Vierhout M. E. Symptomatic pelvic organ prolapse and possible risk factors in a general population. Am J Obstet Gynecol 2009; 200 (184): e1–7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lince SL, van Kempen LC, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J 2012; 23: 1327.</mixed-citation><mixed-citation xml:lang="en">Lince SL, van Kempen LC, Vierhout ME, Kluivers KB. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J 2012; 23: 1327.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Altman D, Forsman M, Falconer C, Lichtenstein P. Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol 2008; 54: 918–922.</mixed-citation><mixed-citation xml:lang="en">Altman D, Forsman M, Falconer C, Lichtenstein P. Genetic influence on stress urinary incontinence and pelvic organ prolapse. Eur Urol 2008; 54: 918–922.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wennberg A-L, Altman D, Lundholm C. Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins. Eur Urol 2011; 59: 1032–1038.</mixed-citation><mixed-citation xml:lang="en">Wennberg A-L, Altman D, Lundholm C. Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins. Eur Urol 2011; 59: 1032–1038.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Milsom I, Altman D, Lapitan MS, Nelson R, Sillén U, Thom D. Epidemiology of Urinary (UI) and Faecal (FI) Incontinence and Pelvic Organ Prolapse (POP). International Continence Society. 2009; Committee 1. 35–112. www.ics.org/Publications/ICI_4/files-book/comite-1.pdf.</mixed-citation><mixed-citation xml:lang="en">Milsom I, Altman D, Lapitan MS, Nelson R, Sillén U, Thom D. Epidemiology of Urinary (UI) and Faecal (FI) Incontinence and Pelvic Organ Prolapse (POP). International Continence Society. 2009; Committee 1. 35–112. www.ics.org/Publications/ICI_4/files-book/comite-1.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cartwright R, Mangera A, Kirby A, et al. PROSPERO: a systematic review of candidate gene association studies of lower urinary tract symptoms and pelvic organ prolapse in women. Available: www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42012001983. Accessed Oct. 4, 2013.</mixed-citation><mixed-citation xml:lang="en">Cartwright R, Mangera A, Kirby A, et al. PROSPERO: a systematic review of candidate gene association studies of lower urinary tract symptoms and pelvic organ prolapse in women. Available: www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42012001983. Accessed Oct. 4, 2013.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cartwright R, Kirby AC, Tikkinen KA, Mangera A. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. Am J Obstet Gynecol 2015; 212 (2): 199. e1–24.</mixed-citation><mixed-citation xml:lang="en">Cartwright R, Kirby AC, Tikkinen KA, Mangera A. Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women. Am J Obstet Gynecol 2015; 212 (2): 199. e1–24.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ward RM, Velez Edwards DR, Edwards T. Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol 2014; 211(4): 326–335.</mixed-citation><mixed-citation xml:lang="en">Ward RM, Velez Edwards DR, Edwards T. Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol 2014; 211(4): 326–335.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Khadzhieva MB, Kolobkov DS, Kamoeva SV, Salnikova LE. Expression changes in pelvic organ prolapse: a systematic review and in silico study. Sci Rep 2017; 7: 7668.</mixed-citation><mixed-citation xml:lang="en">Khadzhieva MB, Kolobkov DS, Kamoeva SV, Salnikova LE. Expression changes in pelvic organ prolapse: a systematic review and in silico study. Sci Rep 2017; 7: 7668.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kim E. J., Chung N., Park S. H., et al. Involvement of oxidative ress and mitochondrial apoptosis in the pathogenesis of pelvic organ prolapse. J Urol. 2013; 189: 588–94. DOI: 10.1016/j.juro.2012.09.041.</mixed-citation><mixed-citation xml:lang="en">Kim E. J., Chung N., Park S. H., et al. Involvement of oxidative ress and mitochondrial apoptosis in the pathogenesis of pelvic organ prolapse. J Urol. 2013; 189: 588–94. DOI: 10.1016/j.juro.2012.09.041.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C., Yang Q., Fang G., et al. Collagen metabolic disorder induced by oxidative stress in human uterosacral ligamentderived fibroblasts: A possible pathophysiological mechanism in pelvic organ prolapse. Mol Med Rep. 2016; 13(4): 2999–3008. DOI:10.3892/mmr.2016.4919.</mixed-citation><mixed-citation xml:lang="en">Liu C., Yang Q., Fang G., et al. Collagen metabolic disorder induced by oxidative stress in human uterosacral ligamentderived fibroblasts: A possible pathophysiological mechanism in pelvic organ prolapse. Mol Med Rep. 2016; 13(4): 2999–3008. DOI:10.3892/mmr.2016.4919.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lefevre R., Davila G. W. Functional disorders: rectocele. Clin Colon Rectal Surg. 2008; 21: 129–37. DOI: 10.1055/s-2008–1075862</mixed-citation><mixed-citation xml:lang="en">Lefevre R., Davila G. W. Functional disorders: rectocele. Clin Colon Rectal Surg. 2008; 21: 129–37. DOI: 10.1055/s-2008–1075862</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Хаджиева М. Б., Камоева С. В., Иванова А. В., Сальникова Л. Е. Генетические факторы коморбидности пролапса тазовых органов, стрессового недержания мочи и хронической венозной недостаточности нижних конечностей у женщин. Генетика. 2018; 54 (12): 1457–65.</mixed-citation><mixed-citation xml:lang="en">Хаджиева М. Б., Камоева С. В., Иванова А. В., Сальникова Л. Е. Генетические факторы коморбидности пролапса тазовых органов, стрессового недержания мочи и хронической венозной недостаточности нижних конечностей у женщин. Генетика. 2018; 54 (12): 1457–65.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Good M. M., Montoya T. I., Shi H.et al. Thermosensitive hydrogels deliver bioactive protein to the vaginal wall. PLoS One. 2017; 12 (10): e0186268. DOI: 10.1371/journal.pone.0186268.</mixed-citation><mixed-citation xml:lang="en">Good M. M., Montoya T. I., Shi H.et al. Thermosensitive hydrogels deliver bioactive protein to the vaginal wall. PLoS One. 2017; 12 (10): e0186268. DOI: 10.1371/journal.pone.0186268.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Klutke J., Stanczyk F. Z., Ji Q., Campeau J. D., Klutke C. G. Suppression of lysyl oxidase gene expression by methylation in pelvic organ prolapse. Int Urogynecol J. 2010; 21 (7): 869–72. DOI: 10.1007/s00192–010–1108–2.</mixed-citation><mixed-citation xml:lang="en">Klutke J., Stanczyk F. Z., Ji Q., Campeau J. D., Klutke C. G. Suppression of lysyl oxidase gene expression by methylation in pelvic organ prolapse. Int Urogynecol J. 2010; 21 (7): 869–72. DOI: 10.1007/s00192–010–1108–2.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Rao S., Lang J., Zhu L., Chen J. Exome sequencing identifies a novel gene, WNK1, for susceptibility to pelvic organ prolapse (POP). PLoS One. 2015 4; 10(3): e0119482. DOI: 10.1371/journal.pone.0119482.</mixed-citation><mixed-citation xml:lang="en">Rao S., Lang J., Zhu L., Chen J. Exome sequencing identifies a novel gene, WNK1, for susceptibility to pelvic organ prolapse (POP). PLoS One. 2015 4; 10(3): e0119482. DOI: 10.1371/journal.pone.0119482.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Serysheva E., Berhane H., Grumolato L., Demir K., Balmer S., Bodak M., et al. Wnk kinases are positive regulators of canonical Wnt/beta-catenin signalling. EMBO Rep. 2013; 14: 718–25. DOI: 10.1038/embor.2013.88.</mixed-citation><mixed-citation xml:lang="en">Serysheva E., Berhane H., Grumolato L., Demir K., Balmer S., Bodak M., et al. Wnk kinases are positive regulators of canonical Wnt/beta-catenin signalling. EMBO Rep. 2013; 14: 718–25. DOI: 10.1038/embor.2013.88.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z., Shi H. H., Chen G., Zhu L. Role of canonical Wnt signaling transduction pathway in the pathogenesis of pelvic organ prolapse. Zhonghua Yi Xue Za Zhi. 2012; 92: 1669–73.</mixed-citation><mixed-citation xml:lang="en">Wang Z., Shi H. H., Chen G., Zhu L. Role of canonical Wnt signaling transduction pathway in the pathogenesis of pelvic organ prolapse. Zhonghua Yi Xue Za Zhi. 2012; 92: 1669–73.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y, Huang J, Hu C, Hua K. Relationship of advanced glycation end products and their receptor to pelvic organ prolapse. Int J Clin Exp Pathol 2015; 8 (3): 2288–2299.</mixed-citation><mixed-citation xml:lang="en">Chen Y, Huang J, Hu C, Hua K. Relationship of advanced glycation end products and their receptor to pelvic organ prolapse. Int J Clin Exp Pathol 2015; 8 (3): 2288–2299.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L, Zheng P, Duan A, Hao Y, Lu C, Lu D. Genome-wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse. Mol Med Rep 2019; 19 (1): 391–399.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Zheng P, Duan A, Hao Y, Lu C, Lu D. Genome-wide DNA methylation analysis of uterosacral ligaments in women with pelvic organ prolapse. Mol Med Rep 2019; 19 (1): 391–399.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Rhee SH, Zhang P, Hunter K, et al. Pelvic organ prolapse is associated with alteration of sphingosine-1-phosphate/Rho-kinase signalling pathway in human vaginal wall. J Obstet Gynaecol 2015; 35: 726–732.</mixed-citation><mixed-citation xml:lang="en">Rhee SH, Zhang P, Hunter K, et al. Pelvic organ prolapse is associated with alteration of sphingosine-1-phosphate/Rho-kinase signalling pathway in human vaginal wall. J Obstet Gynaecol 2015; 35: 726–732.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
